-transparent.png){kind=logo}
A broad phase II study of cis-dichlorodiammineplatinum(II) was conducted. Eight patients with stage IVB Hodgkin's disease were studied. Four of these patients attained an objective partial remission of 7--19+ weeks' duration. The usual time to the occurrence of a greater than 25% response was 1 week. This drug is active in far-advanced Hodgkin's disease with a projected lower limit of response rate from 19% to 21%.
Related Publications
M P Corder, and
T E Elliott, and
L C Maguire, and
J T Leimert, and
S K Panther, and
P A Lachenbruch
April 1984,
Gan to kagaku ryoho. Cancer & chemotherapy,
M P Corder, and
T E Elliott, and
L C Maguire, and
J T Leimert, and
S K Panther, and
P A Lachenbruch
April 1977,
Medizinische Klinik,
M P Corder, and
T E Elliott, and
L C Maguire, and
J T Leimert, and
S K Panther, and
P A Lachenbruch
July 1981,
Klinische Wochenschrift,
M P Corder, and
T E Elliott, and
L C Maguire, and
J T Leimert, and
S K Panther, and
P A Lachenbruch
November 1984,
Cancer,
M P Corder, and
T E Elliott, and
L C Maguire, and
J T Leimert, and
S K Panther, and
P A Lachenbruch
October 1991,
Cancer,
M P Corder, and
T E Elliott, and
L C Maguire, and
J T Leimert, and
S K Panther, and
P A Lachenbruch
August 1986,
Cancer treatment reports,
M P Corder, and
T E Elliott, and
L C Maguire, and
J T Leimert, and
S K Panther, and
P A Lachenbruch
June 2004,
Revue des maladies respiratoires,
M P Corder, and
T E Elliott, and
L C Maguire, and
J T Leimert, and
S K Panther, and
P A Lachenbruch
April 1982,
Gan to kagaku ryoho. Cancer & chemotherapy,
M P Corder, and
T E Elliott, and
L C Maguire, and
J T Leimert, and
S K Panther, and
P A Lachenbruch
March 1982,
Gan to kagaku ryoho. Cancer & chemotherapy,
M P Corder, and
T E Elliott, and
L C Maguire, and
J T Leimert, and
S K Panther, and
P A Lachenbruch
January 1975,
The American journal of roentgenology, radium therapy, and nuclear medicine,
